Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)
China flag China · Delayed Price · Currency is CNY
28.10
-1.25 (-4.26%)
At close: Feb 2, 2026

SHE:002773 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
3,8285,6904,7023,5852,9393,328
Trading Asset Securities
2,565--100200-
Cash & Short-Term Investments
6,3935,6904,7023,6853,1393,328
Cash Growth
15.29%21.00%27.59%17.41%-5.67%45.71%
Accounts Receivable
166.93177.85160.41160.69204.63346.2
Other Receivables
8.9823.0428.8127.8843.5925.57
Receivables
175.9200.89189.22188.57248.22371.77
Inventory
386.24386.86403.61330.96295.62239.64
Other Current Assets
67.9311.5610.6324.2215.8922.77
Total Current Assets
7,0236,2895,3064,2293,6993,962
Property, Plant & Equipment
2,2612,3532,4112,5532,0971,781
Long-Term Investments
15.9716.4416.7816.9817.7318.35
Goodwill
-----214.84
Other Intangible Assets
363.12286.89316.8331.14278.21294.16
Long-Term Deferred Tax Assets
136.31259.46358.08486.31545.66430.01
Long-Term Deferred Charges
37.28123.2499.3370.4784.6755.56
Other Long-Term Assets
33.4814.4822.0133.93233.89245.29
Total Assets
9,8709,3428,5307,7216,9567,001
Accounts Payable
208.57297.16344.03409.54343.13288.87
Accrued Expenses
27.11233.88203.64169.59174.63193.52
Current Portion of Leases
1.471.730.531.62.57-
Current Income Taxes Payable
65.3913.319.8219.6916.4937.45
Current Unearned Revenue
5.368.925.19.148.3911.84
Other Current Liabilities
370.2999.9891.3184.1122.16448.02
Total Current Liabilities
678.19654.99654.43693.66667.37979.7
Long-Term Leases
2.23.471.483.274.43-
Long-Term Unearned Revenue
29.1223.5822.9430.325.5151.4
Long-Term Deferred Tax Liabilities
10.4713.037.945.142.062.37
Other Long-Term Liabilities
--30.9681.48151.71211.88
Total Liabilities
719.98695.07717.76813.85851.081,245
Common Stock
921.32919.78919.46919.46919.46919.46
Additional Paid-In Capital
2,0281,9971,9901,9941,9861,981
Retained Earnings
6,2185,7384,8963,9893,1852,856
Comprehensive Income & Other
-1.65-1.33-1.34-1.05-0.83-0.4
Total Common Equity
9,1668,6537,8046,9026,0905,756
Minority Interest
-16.31-6.347.895.0715.24-
Shareholders' Equity
9,1508,6477,8126,9076,1055,756
Total Liabilities & Equity
9,8709,3428,5307,7216,9567,001
Total Debt
3.685.22.014.877-
Net Cash (Debt)
6,3895,6844,7003,6813,1323,328
Net Cash Growth
15.36%20.94%27.70%17.52%-5.88%45.72%
Net Cash Per Share
6.956.205.134.023.423.82
Filing Date Shares Outstanding
921.32919.78919.46919.46919.46919.46
Total Common Shares Outstanding
921.32919.78919.46919.46919.46919.46
Working Capital
6,3455,6344,6513,5353,0312,982
Book Value Per Share
9.959.418.497.516.626.26
Tangible Book Value
8,8038,3667,4876,5715,8125,247
Tangible Book Value Per Share
9.569.108.147.156.325.71
Buildings
-2,1261,9891,7851,137-
Machinery
-1,2711,2361,088830.91-
Construction In Progress
-112.35166.54475.88808.69-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.